TrademarkDir
Serial #79313378
LIVE

Serial Number

79313378

Owner

Myrio Therapeutics Pty Ltd

Attorney

Brendan J. Hughes

Filing Date

Mar 19, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #79313378 Trademark

Serial Number: 79313378 • Registration: 6810857

Serial #79313378 is a trademark filed by Myrio Therapeutics Pty Ltd on March 19, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Myrio Therapeutics Pty Ltd (2 trademarks)

17 Carranya Rd

Entity Type: 03

Trademark Details

Filing Date

March 19, 2021

Registration Date

August 9, 2022

Published for Opposition

May 24, 2022

Goods & Services

Therapeutic antibodies for the treatment of autoimmune diseases, oncological diseases, viruses; biological preparations for pharmaceutical purposes for the treatment of autoimmune diseases, oncological diseases, viruses; pharmaceutical preparations for treating autoimmune diseases, oncological diseases, viruses; pharmaceutical compositions for treating autoimmune diseases, oncological diseases, virus

Antibodies for scientific purposes, other than for medical or veterinary use; biological preparations for laboratory purposes; biological preparations for use in science and industry, namely, for use in the pharmaceutical industry; chemical preparations for use in science; chemical preparations for use in the pharmaceutical industry

Scientific laboratory services for scientific research or analysis; laboratory research in the field of biology; scientific research

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 12, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 18, 2022 FICS
FINAL DISPOSITION PROCESSED
Nov 18, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 9, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 9, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 9, 2022 R.PR
NOTIFICATION PROCESSED BY IB
May 24, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 24, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 24, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 4, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 4, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 4, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 21, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 19, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 11, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 11, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 11, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 11, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 11, 2022 COAR
REFUSAL PROCESSED BY IB
Dec 13, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 23, 2021 RFCS
REFUSAL PROCESSED BY MPU
Nov 23, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 26, 2021 RFCR
NON-FINAL ACTION WRITTEN
Oct 25, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 24, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 26, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 17, 2021 REPR

Related Trademarks

More from this Owner

MYRIO THERAPEUTICS

MYRIO THERAPEUTICS

MYRIO THERAPEUTICS

MYRIO THERAPEUTICS

MYRIO THERAPEUTICS

MYRIO THERAPEUTICS